Home > Insider Trading > Tg Therapeutics Inc.

Tg Therapeutics Inc. (TGTX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
41 - 50

Hedge Fund and Insider Trading News: Chase Coleman, Kyle Bass, Elliott Management, Eloxx Pharmaceuticals Inc (ELOX), TG Therapeutics Inc (TGTX), and More

Hedge fund manager Kyle Bass stepped down from the board of Texas’s state university endowment after almost a decade.

Keep Reading →

June 27th, 2019 - Hedge Funds Insider Trading

Hedge Funds Are Buying TG Therapeutics Inc (TGTX)

"Value has performed relatively poorly since the 2017 shift, but we believe challenges to the S&P 500’s dominance are mounting and resulting active opportunities away from the index are growing.

Keep Reading →

December 18th, 2018 - Hedge Funds News

This Biotech Investor's Picks Returned 31% in Q1; Here Are Its New Bets

Peter Kolchinsky is one of the best biotech investors and many of his stock picks generate strong returns.

Keep Reading →

June 12th, 2018 - Hedge Funds News

Here's What's Next For TG Therapeutics Inc (TGTX)

TG Therapeutics Inc (NASDAQ:TGTX) is a big runner this week, with the company up close t 90% during Monday’s session alone out of the US.

Keep Reading →

March 7th, 2017 - News Stock Analysis

Should You Worry About What TG Therapeutics Inc (NASDAQ:TGTX) Has Just Done?

TG Therapeutics Inc (NASDAQ:TGTX) has unexpectedly altered the protocol for the GENUINE Phase 3 clinical trial of its lead drug candidate TG-1101.

Keep Reading →

October 19th, 2016 - News Stock Analysis

5 Nasdaq Stocks Crashing to 52-Week Lows This Week

The U.S stock indexes hit record highs on Monday, helped by Bank of America Corp (NYSE:BAC)’s better than expected financial results and some M&A activity in the tech sector.

Keep Reading →

July 20th, 2016 - Market Movers News Tech

Is TG Therapeutics Inc (TGTX) A Good Stock To Buy?

Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money because they are without...

Keep Reading →

December 12th, 2015 - Hedge Funds News

Hedge Funds Are Buying Shares of These Two Bio-tech Stocks; Should You?

Is it a good time to buy Kite Pharma Inc (NASDAQ:KITE)? Andreas Halvorsen seems to think so, having recently increased his holding of the stock.

Keep Reading →

October 6th, 2015 - Hedge Funds News

Synergy Pharmaceuticals Inc (SGYP), Proteon Therapeutics Inc (PRTO): James E. Flynn and Peter Kolchinsky Think These Stocks Look Healthy

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Proteon Therapeutics Inc (NASDAQ:PRTO) are in the spotlight as James E.

Keep Reading →

November 3rd, 2014 - Hedge Funds News

The Medicines Company (MDCO), TG Therapeutics Inc (TGTX): Bridger Management & Ra Capital Management Taking Plunge

In the last few days, we have seen a lot of capital from funds that we track getting shifted to pharmaceutical stocks and no it’s not just sector specific funds, but funds across board.

Keep Reading →

October 21st, 2014 - Hedge Funds News